Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to -$5.2 million.

  • BridgeBio Pharma's Other Working Capital Changes fell 21414.81% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year decrease of 394.88%. This contributed to the annual value of $21.9 million for FY2024, which is 50226.19% up from last year.
  • Latest data reveals that BridgeBio Pharma reported Other Working Capital Changes of -$5.2 million as of Q3 2025, which was down 21414.81% from $25.3 million recorded in Q2 2025.
  • BridgeBio Pharma's Other Working Capital Changes' 5-year high stood at $25.3 million during Q2 2025, with a 5-year trough of -$7.9 million in Q1 2022.
  • Over the past 5 years, BridgeBio Pharma's median Other Working Capital Changes value was -$390000.0 (recorded in 2021), while the average stood at $3.1 million.
  • Per our database at Business Quant, BridgeBio Pharma's Other Working Capital Changes surged by 639282.05% in 2022 and then plummeted by 49024.39% in 2023.
  • Over the past 5 years, BridgeBio Pharma's Other Working Capital Changes (Quarter) stood at $886000.0 in 2021, then plummeted by 292.66% to -$1.7 million in 2022, then skyrocketed by 42.94% to -$974000.0 in 2023, then soared by 233.47% to $1.3 million in 2024, then crashed by 501.38% to -$5.2 million in 2025.
  • Its last three reported values are -$5.2 million in Q3 2025, $25.3 million for Q2 2025, and -$2.6 million during Q1 2025.